DuPont de Nemours Inc.

4 days ago · prnewswire.com

SBTi validation recognizes DuPont's continued climate progress, with new 2035 emissions-reduction targets and a 2050 net-zero target WILMINGTON, Del., Oct. 29, 2026 /PRNewswire/ -- DuPont (NYSE: DD) today announced that its net-zero science-based greenhouse gas (GHG) emissions reduction targets have been validated by the Science Based Targets initiative (SBTi).

10 days ago · zacks.com

DD expands its bioprocessing portfolio with AmberChrom SIL silica gel, targeting high-purity peptide purification amid growing demand for GLP-1 therapeutics.

13 days ago · 247wallst.com

Six industrial giants are selling off divisions while keeping payouts high, and the cash flow numbers behind those yields tell a very different story than the headline percentages suggest.

14 days ago · zacks.com

DuPont's innovation investments, healthcare acquisitions and productivity gains support growth as it raises 2026 earnings guidance amid persistent cost pressures.

20 days ago · prnewswire.com

WILMINGTON, Del., Oct. 13, 2026 /PRNewswire/ -- DuPont (NYSE: DD) today announced that its Board of Directors has declared a quarterly dividend of sixty cents ($0.60) per share on the outstanding Common Stock of the Company (par value $0.01 per share) payable on December 15, 2026, to holders of record of said stock at the close of business on November 30, 2026.

27 days ago · prnewswire.com

WILMINGTON, Del., Oct. 6, 2026 /PRNewswire/ -- DuPont (NYSE: DD) will release its third quarter 2026 financial results at 6:00 a.m.

1 month ago · zacks.com

DD launches a digital tool using chromatography data to help sugar and sweetener makers assess separation options and identify resins.

1 month ago · prnewswire.com

Digital tool draws on extensive laboratory separation data to help sugar and sweetener producers identify best-fit DuPont™ AmberLite™ chromatography resins for Food & Beverage ingredient applications. WILMINGTON, Del.

1 month ago · seekingalpha.com

DuPont is rated Buy, offering secular growth and margin expansion at an attractive valuation, with strong exposure to healthcare, water, EV, and aerospace markets. Healthcare and Water Technologies drive structural growth, supported by leading positions in medical devices and semiconductor water treatment, with resilient recurring revenues. The Diversified Industrials segment benefits from EV battery adhesives and aerospace, with growth initiatives and margin expansion through 80/20 simplification and productivity programs.

1 month ago · gurufocus.com

Caliway Announces Positive Phase 2 Results of CBL-514 in Dercum's Disease, Achieving Primary Endpoint with Statistically Significant and Sustained Pain Reductio